• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重急性呼吸综合征冠状病毒2中和抗体反应以及两种血清学检测方法与微量中和试验的相关性

SARS-CoV-2-Neutralizing Antibody Response and Correlation of Two Serological Assays with Microneutralization.

作者信息

Souiri Amal, Lemriss Sanaâ, El Maliki Bouchra, Falahi Hamadi, El Fahime Elmostafa, El Kabbaj Saâd

机构信息

Laboratory of Research and Medical Analysis of Gendarmerie Royale, Department of Biosafety PCL3, Rabat 10100, Morocco.

Faculty of Medecine and Pharmacy, University Hassan II, Casablanca 20250, Morocco.

出版信息

Vaccines (Basel). 2023 Mar 3;11(3):590. doi: 10.3390/vaccines11030590.

DOI:10.3390/vaccines11030590
PMID:36992173
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10054367/
Abstract

SARS-CoV-2 has caused a huge pandemic affecting millions of people and resulting innumerous deaths. A better understanding of the correlation between binding antibodies and neutralizing antibodies is necessary to address protective immunity post-infection or vaccination. Here, we investigate the humoral immune response and the seroprevalence of neutralizing antibodies following vaccination with adenovirus-based vector in 177 serum samples. A Microneutralization (MN) assay was used as a reference method to assess whether neutralizing antibody titers correlated with a positive signal in two commercially available serological tests:a rapid lateral flow immune-chromatographic assay (LFIA) and an enzyme-linked Fluorescence Assay (ELFA). Neutralizing antibodies were detected in most serum samples (84%). COVID-19 convalescent individuals showed high antibody titers and significant neutralizing activity. Spearman correlation coefficients between the serological and neutralization results ranged from 0.8 to 0.9, suggesting a moderate to strong correlation between commercial immunoassays test results (LFIA and ELFA) and virus neutralization.

摘要

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引发了一场巨大的全球大流行,影响了数百万人并导致无数人死亡。为了解决感染后或接种疫苗后的保护性免疫问题,有必要更好地理解结合抗体与中和抗体之间的相关性。在此,我们对177份血清样本进行研究,调查基于腺病毒载体接种疫苗后的体液免疫反应和中和抗体的血清流行率。微量中和(MN)试验用作参考方法,以评估中和抗体滴度是否与两种市售血清学检测中的阳性信号相关:快速侧向流动免疫层析试验(LFIA)和酶联荧光试验(ELFA)。大多数血清样本(84%)中检测到了中和抗体。新冠康复者显示出高抗体滴度和显著的中和活性。血清学检测结果与中和结果之间的斯皮尔曼相关系数在0.8至0.9之间,表明市售免疫分析检测结果(LFIA和ELFA)与病毒中和之间存在中度至强相关性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85be/10054367/e77cad85a19b/vaccines-11-00590-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85be/10054367/f3404249b587/vaccines-11-00590-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85be/10054367/8d005a915894/vaccines-11-00590-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85be/10054367/d7b15121093d/vaccines-11-00590-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85be/10054367/4041e90dcd5a/vaccines-11-00590-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85be/10054367/f2a9d0c1ce07/vaccines-11-00590-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85be/10054367/e77cad85a19b/vaccines-11-00590-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85be/10054367/f3404249b587/vaccines-11-00590-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85be/10054367/8d005a915894/vaccines-11-00590-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85be/10054367/d7b15121093d/vaccines-11-00590-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85be/10054367/4041e90dcd5a/vaccines-11-00590-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85be/10054367/f2a9d0c1ce07/vaccines-11-00590-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85be/10054367/e77cad85a19b/vaccines-11-00590-g006.jpg

相似文献

1
SARS-CoV-2-Neutralizing Antibody Response and Correlation of Two Serological Assays with Microneutralization.严重急性呼吸综合征冠状病毒2中和抗体反应以及两种血清学检测方法与微量中和试验的相关性
Vaccines (Basel). 2023 Mar 3;11(3):590. doi: 10.3390/vaccines11030590.
2
Evaluating Humoral Immunity against SARS-CoV-2: Validation of a Plaque-Reduction Neutralization Test and a Multilaboratory Comparison of Conventional and Surrogate Neutralization Assays.评估针对 SARS-CoV-2 的体液免疫:蚀斑减少中和试验的验证和常规及替代中和测定法的多实验室比较。
Microbiol Spectr. 2021 Dec 22;9(3):e0088621. doi: 10.1128/Spectrum.00886-21. Epub 2021 Nov 17.
3
Evaluation of 6 Commercial SARS-CoV-2 Serology Assays Detecting Different Antibodies for Clinical Testing and Serosurveillance.评估6种用于临床检测和血清学监测的检测不同抗体的新型冠状病毒2型血清学检测方法
Open Forum Infect Dis. 2021 May 10;8(7):ofab239. doi: 10.1093/ofid/ofab239. eCollection 2021 Jul.
4
Evaluation of Three Quantitative Anti-SARS-CoV-2 Antibody Immunoassays.三种定量抗 SARS-CoV-2 抗体免疫分析方法的评估。
Microbiol Spectr. 2021 Dec 22;9(3):e0137621. doi: 10.1128/spectrum.01376-21.
5
Correlation of the Commercial Anti-SARS-CoV-2 Receptor Binding Domain Antibody Test with the Chemiluminescent Reduction Neutralizing Test and Possible Detection of Antibodies to Emerging Variants.商业抗 SARS-CoV-2 受体结合域抗体检测与化学发光减少中和检测的相关性,以及对新兴变异体抗体的可能检测。
Microbiol Spectr. 2021 Dec 22;9(3):e0056021. doi: 10.1128/Spectrum.00560-21. Epub 2021 Dec 1.
6
Inference of SARS-CoV-2 spike-binding neutralizing antibody titers in sera from hospitalized COVID-19 patients by using commercial enzyme and chemiluminescent immunoassays.使用商业酶联免疫吸附试验和化学发光免疫分析方法推断住院 COVID-19 患者血清中 SARS-CoV-2 刺突结合中和抗体效价。
Eur J Clin Microbiol Infect Dis. 2021 Mar;40(3):485-494. doi: 10.1007/s10096-020-04128-8. Epub 2021 Jan 6.
7
An Assessment of Serological Assays for SARS-CoV-2 as Surrogates for Authentic Virus Neutralization.SARS-CoV-2 血清学检测作为真实病毒中和的替代指标的评估。
Microbiol Spectr. 2021 Oct 31;9(2):e0105921. doi: 10.1128/Spectrum.01059-21. Epub 2021 Oct 27.
8
SARS Coronavirus-2 Microneutralisation and Commercial Serological Assays Correlated Closely for Some but Not All Enzyme Immunoassays.严重急性呼吸系统综合征冠状病毒-2 微量中和与一些而非所有酶免疫测定法的商业血清学检测密切相关。
Viruses. 2021 Feb 4;13(2):247. doi: 10.3390/v13020247.
9
Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing Titers.五种市售血清学检测方法检测 SARS-CoV-2 抗体的性能比较及识别高中和抗体滴度个体。
J Clin Microbiol. 2021 Jan 21;59(2). doi: 10.1128/JCM.02257-20.
10
Comprehensive Comparison of Seven SARS-CoV-2-Specific Surrogate Virus Neutralization and Anti-Spike IgG Antibody Assays Using a Live-Virus Neutralization Assay as a Reference.使用活病毒中和试验作为参考,对七种 SARS-CoV-2 特异性替代病毒中和和抗刺突 IgG 抗体检测方法进行全面比较。
Microbiol Spectr. 2023 Feb 14;11(1):e0231422. doi: 10.1128/spectrum.02314-22. Epub 2023 Jan 9.

引用本文的文献

1
SARS-CoV-2 immune responses in patients with multiple myeloma and lenalidomide maintenance therapy.多发性骨髓瘤患者的SARS-CoV-2免疫反应及来那度胺维持治疗
Front Immunol. 2024 Dec 18;15:1510942. doi: 10.3389/fimmu.2024.1510942. eCollection 2024.
2
Immunogenicity of two-dose sinopharm BBIB-CorV vaccine in Morocco: One-year follow-up and neutralizing activity against severe acute respiratory syndrome coronavirus 2 variants of concern.摩洛哥两剂国药 BBIB-CorV 疫苗的免疫原性:一年随访及对严重急性呼吸综合征冠状病毒 2 关切变异株的中和活性。
Immun Inflamm Dis. 2024 Nov;12(11):e1359. doi: 10.1002/iid3.1359.
3
The Anti-SARS-CoV-2 S-Protein IgG, Which Is Detected Using the Chemiluminescence Microparticle Immunoassay (CMIA) in Individuals Having Either a History of COVID-19 Vaccination and/or SARS-CoV-2 Infection, Showed a High-Titer Neutralizing Effect.

本文引用的文献

1
Overview of Neutralization Assays and International Standard for Detecting SARS-CoV-2 Neutralizing Antibody.中和抗体检测概述及 SARS-CoV-2 中和抗体检测国际标准。
Viruses. 2022 Jul 18;14(7):1560. doi: 10.3390/v14071560.
2
Persistence of immunity and impact of third dose of inactivated COVID-19 vaccine against emerging variants.新冠病毒灭活疫苗第三针接种后免疫持久性及对新型变异株的影响
Sci Rep. 2022 Jul 14;12(1):12038. doi: 10.1038/s41598-022-16097-3.
3
Immunological memory to SARS-CoV-2 infection and COVID-19 vaccines.对 SARS-CoV-2 感染和 COVID-19 疫苗的免疫记忆。
用化学发光微粒子免疫分析(CMIA)检测到的针对 SARS-CoV-2 刺突蛋白 IgG 的抗体,在有 COVID-19 疫苗接种史和/或 SARS-CoV-2 感染史的个体中,显示出高滴度的中和作用。
Viruses. 2024 Sep 3;16(9):1409. doi: 10.3390/v16091409.
4
A novel immunofluorescent test system for SARS-CoV-2 detection in infected cells.一种用于检测感染细胞中 SARS-CoV-2 的新型免疫荧光检测系统。
PLoS One. 2024 May 31;19(5):e0304534. doi: 10.1371/journal.pone.0304534. eCollection 2024.
5
Sero-epidemiological investigation and cross-neutralization activity against SARS-CoV-2 variants in cats and dogs, Thailand.泰国猫和狗针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变体的血清流行病学调查及交叉中和活性
Front Vet Sci. 2024 May 6;11:1329656. doi: 10.3389/fvets.2024.1329656. eCollection 2024.
6
Vaccine Based on Recombinant Fusion Protein Combining Hepatitis B Virus PreS with SARS-CoV-2 Wild-Type- and Omicron-Derived Receptor Binding Domain Strongly Induces Omicron-Neutralizing Antibodies in a Murine Model.基于重组融合蛋白的疫苗,该融合蛋白将乙肝病毒前S区与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)野生型和奥密克戎变异株衍生的受体结合域相结合,在小鼠模型中强烈诱导奥密克戎中和抗体。
Vaccines (Basel). 2024 Feb 23;12(3):229. doi: 10.3390/vaccines12030229.
7
IgG responses against SARS-CoV-2 vaccines AZD1222 and BBV-152 and breakthrough infections among health care workers in southern India.印度南部医护人员针对新冠病毒疫苗AZD1222和BBV-152的IgG反应及突破性感染情况
Heliyon. 2024 Jan 30;10(3):e25528. doi: 10.1016/j.heliyon.2024.e25528. eCollection 2024 Feb 15.
8
Effective Neutralizing Antibody Response Against SARS-CoV-2 Virus and Its Omicron BA.1 Variant in Fully Vaccinated Hematological Patients.完全接种疫苗的血液系统疾病患者对 SARS-CoV-2 病毒及其奥密克戎 BA.1 变异株的有效中和抗体反应。
Clin Exp Med. 2023 Dec;23(8):4943-4953. doi: 10.1007/s10238-023-01223-w. Epub 2023 Oct 28.
Immunol Rev. 2022 Sep;310(1):27-46. doi: 10.1111/imr.13089. Epub 2022 Jun 22.
4
Anti-SARS-CoV-2 Neutralizing Antibody Responses after Two Doses of ChAdOx1 nCoV-19 vaccine (AZD1222) in Healthcare Workers.医护人员接种两剂ChAdOx1 nCoV-19疫苗(AZD1222)后的抗SARS-CoV-2中和抗体反应
Infect Chemother. 2022 Mar;54(1):140-152. doi: 10.3947/ic.2022.0009.
5
Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants.接种疫苗无论是在感染 SARS-CoV-2 之前还是之后,都会引发强烈的体液免疫反应和能够有效中和变异株的抗体。
Sci Immunol. 2022 Feb 18;7(68):eabn8014. doi: 10.1126/sciimmunol.abn8014.
6
Dynamics of Neutralizing Antibody Responses Following Natural SARS-CoV-2 Infection and Correlation with Commercial Serologic Tests. A Reappraisal and Indirect Comparison with Vaccinated Subjects.自然感染 SARS-CoV-2 后中和抗体反应的动力学及其与商业血清学检测的相关性。再评价及与接种疫苗人群的间接比较。
Viruses. 2021 Nov 22;13(11):2329. doi: 10.3390/v13112329.
7
Evidence for retained spike-binding and neutralizing activity against emerging SARS-CoV-2 variants in serum of COVID-19 mRNA vaccine recipients.在 COVID-19 mRNA 疫苗接种者的血清中发现针对新型 SARS-CoV-2 变异株的刺突结合和中和活性保留。
EBioMedicine. 2021 Nov;73:103626. doi: 10.1016/j.ebiom.2021.103626. Epub 2021 Oct 20.
8
Post-SARS-CoV-2 vaccination specific antibody decrease - Thresholds for determining seroprevalence and seroneutralization differ.新型冠状病毒肺炎疫苗接种后特异性抗体下降——确定血清阳性率和血清中和的阈值不同。
J Infect. 2021 Oct;83(4):e4-e5. doi: 10.1016/j.jinf.2021.08.023. Epub 2021 Aug 15.
9
Reduced Risk of Reinfection with SARS-CoV-2 After COVID-19 Vaccination - Kentucky, May-June 2021.2021 年 5 月至 6 月,美国肯塔基州,新冠疫苗接种后感染 SARS-CoV-2 的再感染风险降低。
MMWR Morb Mortal Wkly Rep. 2021 Aug 13;70(32):1081-1083. doi: 10.15585/mmwr.mm7032e1.
10
Performance of the rapid high-throughput automated electrochemiluminescence immunoassay targeting total antibodies to the SARS-CoV-2 spike protein receptor binding domain in comparison to the neutralization assay.针对 SARS-CoV-2 刺突蛋白受体结合域的总抗体的快速高通量自动化电化学发光免疫分析与中和测定的比较性能。
J Clin Virol. 2021 Jun;139:104820. doi: 10.1016/j.jcv.2021.104820. Epub 2021 Apr 10.